By Lisa Lamya
BLANTYRE-(MANA)-President Lazarus Chakwera has launched the Clinical Research Excellence and Training Open Resource Centre (CREATOR) in Blantyre, with a call for researchers to ensure they conduct research that adds value to national development.
The magnificent CREATOR building valued at 9.5 million Pound Sterling (equivalent of MK19 billion) has been built by the Liverpool Welcome Programme (MLW) with funding from the Welcome Trust with additional funding from the University of Liverpool and the Liverpool School of Tropical Medicine.
“Government is committed to create an enabling environment for scientific research to thrive and the launch of this building will help Malawi address critical health problems,” said Chakwera.
Chakwera expressed optimism that through various research that will be conducted at the CREATOR building, issues of counterfeit drugs will be addressed.
In his remarks, Professor Henry Mwandumba, Director of the Malawi-Liverpool Wellcome Trust Programme, reaffirmed MLWTs commitment to complement governments efforts in the attainment of the Malawi 2063 Agenda.
Mwandumba said the realisation of the agenda is dependent upon a healthy nation, adding: “MLWT believes that the launch of CREATOR will provide an environment for high quality research that will contribute to health policies and a healthy nation.”
Vice Chancellor for Kamuzu University of Health Sciences, Dr. Macpherson Mallewa described the launch of the CREATOR as key in achieving research excellence in Malawi.
“As partners, KUHES is geared to take health research to greater heights and the CREATOR building is a facility that will be critical to this cause,” Mallewa stated.
Minister of Education, Madalitso Kambauwa Wirima said the creator is a game changer for Malawi.
“Research conducted by MLWT has made a significant impact on Malawis health sector just to mention that MLWT is behind the creation of the Typhoid Conjugate Vaccine which is administered to children in Malawi,” Kambauwa disclosed.
Discover more from
Subscribe to get the latest posts sent to your email.